Looks as the stock is about to break the downtrend and get ready for the reversal.
Supply chain disruption held many manufacturing companies from driving up revenues and profits.
Yet, this is temporary and the fact the Corsair's management retained FY outlook for revenue is encouraging factor.
Series of negative events and environment was dragging down the stock.
Key resistance of 9.2 was not broken in August, taking it into downtrend.
Yet, the fundamentally the company is undervalued and flies under radar.
It will start grasping more attention as COVISTIX and G-MAB library products will continue progressing with approvals.
In short term TA...
I'm long in this stock and been studying it for quite a well.
Strong pipeline and recent news on agreement with Texas A&M University System around one of it's development related to fighting Covid-19 by inhibiting MPro enzyme.
The company also has several other programs to address Covid-19 as well as cancer, immunological diseases and pain.
Long-term symmetrical triangle
+ short-term ascending triangle
+ analysts average consensus being at current level suggests
+ MA 200 and 50 meeting in the point
+ MACD in slightly bullish
+ RCI neutral (42)
+ volumes at 20-day average
Indecision picture overall.
What's next? Testing 20 support? Or breaking 22.7?
I'm long with small LEAPs.
After overreaction and panic sales and FUD driven by minor miss on earnings, the price almost closed the gap.
Important resistance to break is 28.5.
Then next key resistance level would be 31.5.
Analysts average rating is 40 with the lowest being at 31.
I'm with small LEAPS position @ 25, 01/23 in this name.
After breaking the key resistance of 25.17, it also passed another level of 26.20.
If 26.20 is confirmed, would it go to take 27.40-27.46?
And, then, once 27.45 is confirmed, we may see another rally up to 30.50.
It may not be the case, as market is volatile; yet, the overall context looks bullish.
Before going to technical part of the story, you may want to check-out this quick read with highlights on David Katz (analyst from Jefferies) putting $28 target in next 12 months.
More here: finance.yahoo.com
Currently, the stock is hovering at key level 15.5 (YTD fib 0.23 and also IPO open).
I expect it to...
Stormy waters seems to be over for the stock after controversial and debated earnings report followed by expiration of lock-up period.
Palantir is much like Microsoft in 90s. Everyone understands the importance of data in the era when business is made @ the speed of thought. Harnessing the power of data, though, is not an easy task at all. There are a lot of...
A lot of bets were made towards the earnings day, which in its turn is linked to lock-up expiration period (3 days after the earnings).
The D-day is about to play out next week, which will also "coincide" with Feb option expiration.
After short & gamma squeeze drama with BANG stocks ($BB, $AMC, $NOK, $GME) earlier in the year, the frenetic market activity...